News Release

2011.12.26

Noven Pharmaceuticals, Inc. press release : Noven announces Phase3 results for investigational non-hormonal therapy for vasomotor symptoms

2011.10.27

Announcement on the Establishment of a Local Corporation in China

2011.10.17

Noven Pharmaceuticals, Inc. press release : Noven files patent infrigement lawsuit against Watson Pharmaceuticals

2011.10.12

FY02/2012 Q2 Results Earnings Release Presentation

2011.09.21

Notification of Termination of Agreement Concerning Co-promotion of Fosamac®

2011.08.11

Phase III Clinical Trial Results for Overactive Bladder Drug HOB-294 (Oxybutynin Hydrochloride, Transdermal Therapeutic Formulation)

2011.07.21

Notice of the availability of Norspan® Tape, a dermally absorbed remedy for persistent pain.

2011.07.07

Announcement on Estimated Business Results and Dividends

2011.07.07

FY02/2012 Q1 Results Earnings Release Presentation

2011.05.26

Notice of Personnel Changes

2011.04.15

Announcement Regarding the Impact of the Great Eastern Earthquake (3rd)

2011.04.08

FY02/2011 Q4 Results Earnings Release Presentation

2011.03.25

Notice of Appointment of Executive Officer

2011.03.25

Notice of Proposed Changes of Directors and Auditors

2011.03.23

Announcement Regarding the Impact of the Tohoku-Pacific Ocean Earthquake (2nd)

2011.03.15

Notice concerning the decision of matters relating to acquisition of company’s own shares. (Acquisition of company’s own shares under the regulations of the articles of association in accordance to paragraph 2, article 165 of the corporation law)

2011.03.15

Announcement Regarding the Impact of the Tohoku-Pacific Ocean Earthquake

2011.03.15

Announcement Regarding Relief Money for the Tohoku-Pacific Ocean Earthquake

2011.02.23

Announcement of the acquisition of marketing approval for transdermal long-acting chronic pain “NORSPAN® TAPE” (development code: BTDS)

2011.02.23

Transdermal Pain Reliever and Anti-Inflammatory “Mohrus Tape®” (Development Code: KPT-220) Notice Pertaining the Acquisition of Approval to Add the Effects Related to “Pain and Inflammation Relief for Acute Disorders and Symptoms”

2011.02.22

Noven Pharmaceuticals, Inc. press release : Noven files patent infrigement lawsuit against Mylan Technologies

2011.01.06

FY02/2011 Q3 Results Earnings Release Presentation